sub:provenance { beldoc:dce:description "Approximately 61,000 statements." ; dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved." ; dce:title "BEL Framework Large Corpus Document" ; pav:authoredBysub:_6 ; pav:version "1.4" . sub:_5prov:value "Figure 3A provides a gel shift analysis in which nuclear extracts isolated from bFGF-treated pulmonary fibroblast cultures were incubated with radiolabeled serum response element (SRE) of the c-Fos promoter. Several major complexes form, including two slow migrating complexes (complexes A and B) and several faster moving complexes (complex C). The addition of phosphorylated Elk-1 antibody abrogates the binding of complex B, demonstrating that phosphorylated Elk-1 is a component of complex B and, more importantly, showing that bFGF treatment results in the phosphorylation of Elk-1 (Fig. 3B). " ; prov:wasQuotedFrompubmed:11557580 . sub:_6rdfs:label "Selventa" . sub:assertionprov:hadPrimarySourcepubmed:11557580 ; prov:wasDerivedFrombeldoc: , sub:_5 . }